Disparity between cost variation of antibiotics in northern and western India: A cross-sectional study

Authors

  • Dr Fatima Khan Jawaharlal Nehru Medical College, AMU, Aligarh Author
  • Zainab Motiwala Jawaharlal Nehru Medical College, AMU, Aligarh Author
  • Shaarif Rauf Khan Jawaharlal Nehru Medical College, AMU, Aligarh Author

DOI:

https://doi.org/10.21276/r70f9n57

Keywords:

Regional disparity, cost variation of antibiotics, AMR development, prescribing

Abstract

Background- About 58% of India’s health expenditure is out of pocket expenditure. There is a wide variation in the cost of different brands of the same generic drug. Prescription of expensive brands of antibiotics contributes to the development of antibiotic resistance. There is literature available on the cost variation and cost ratio of antibiotics but none on the regional disparity.

Materials and Methods- An observational cross-sectional study design was adopted. The study was conducted at the medical stores of Aligarh (Uttar Pradesh) and Mumbai (Maharashtra). The maximum and minimum cost/unit in Rupees (INR) of each antibiotic manufactured by multiple pharmaceutical companies was noted. Furthermore, Cost per daily defined dose (cost/DDD) was calculated for the most expensive and least expensive drug.

Results-

ALIGARH- The highest percent cost variation of 1897.14 and cost ratio of 19.97 was found for Piperacillin 4000mg + Tazobactam 500mg tablets. The least percent cost variation of 48.92 and cost ratio of 1.49 was found for ciprofloxacin 200mg vial.

MUMBAI- The highest cost variation of 3031.05 and cost ratio of 31.31 was found for cefixime 200 mg tablets. The least percent cost variation of 6.43 and cost ratio of 1.06 was found for ciprofloxacin 200 mg vial.

Conclusions- There is disparity in the cost variation and ratio between the two cities Aligarh and Mumbai in this study, which can be attributed to availability of different brands, under a generic group, in the different regions of the country.

Downloads

Download data is not yet available.

References

Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: A systematic

review. PLoS Med. 2007;4(9): e283

WHO Global Health Expenditure Atlas; 2014. Available from: http://www.

who.int/health-accounts/atlas2014.pdf

Dinesh Kumar Meena, Jayanti Mathiyan. Cost analysis of different antibiotic

brands available in Indian market with reference to National List of Essential

Medicines. Indian Journal of Community Medicine 2021; 46(1)

Report of the Core-Committee for Revision of National List of Essential

Medicines. November,2015.

Gupta RK, Reddy PS. A calm look on cost analysis of different brands of antiepileptic drug. J MGIMS. 2011; 16(i):64-

Shakeel Ahmad Mir. Cost analysis of different brands of antimicrobial agents

available in India. International Journal of Basic &Clinical Pharmacology 2016;

(1)

Downloads

Published

06.12.2022

Issue

Section

ORIGINAL ARTICLES ~ Pharmacology

Similar Articles

1-10 of 136

You may also start an advanced similarity search for this article.